Zobrazeno 1 - 10
of 137
pro vyhledávání: '"O'Brien, FL"'
Autor:
Grayling, A.C, Goulder, Naomi, Pyle, Andrew
Publikováno v:
The Continuum Encyclopedia of British Philosophy, 1 ed., 2010.
Autor:
Mantegazza, R, Wolfe, GI, Muppidi, S, Wiendl, H, Fujita, KP, O'Brien, FL, Booth, HDE, Howard, JF, Illa I., Cortés-Vicente E., Díaz-Manera J., Querol L.A., Rojas-García R., Vidal-Fernandez N., REGAIN Study Group
Publikováno v:
NEUROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Objective To evaluate whether eculizumab helps patients with anti-acetylcholine receptor-positive (AChR+) refractory generalized myasthenia gravis (gMG) achieve the Myasthenia Gravis Foundation of America (MGFA) post-intervention status of minimal ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::93c76f5ed578cc0c5f93c483f596575f
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7922
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7922
Publikováno v:
Continuum Encyclopedia of British Philosophy; 2006, Vol. 3, p2037-2037, 1/4p
Autor:
Muppidi, S, Utsugisawa, K, Benatar, M, Murai, H, Barohn, RJ, Illa, I, Jacob, S, Vissing, J, Burns, TM, Kissel, JT, Nowak, RJ, Andersen, H, Casasnovas, C, de Bleecker, JL, Vu, TH, Mantegazza, R, O'Brien, FL, Wang, JJ, Fujita, KP, Howard, JF, Kaya, A, Khursigara, G, Armstrong, R, Diab, D, Capocelli, K, Lane, C, Sanders, V, Gandolfo, R, REGAIN Study Grp
Publikováno v:
MUSCLE & NERVE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Introduction: Eculizumab is effective and well tolerated in patients with antiacetylcholine receptor antibody-positive refractory generalized myasthenia gravis (gMG; REGAIN; NCT01997229). We report an interim analysis of an open-label extension of RE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::5c85c74958e047c20f2e7ab4bd48c959
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2597
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2597
Autor:
Howard JF Jr; Department of Neurology, The University of North Carolina, Chapel Hill, North Carolina, USA., Karam C; Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA., Yountz M; Alexion Pharmaceuticals, Inc., Boston, Massachusetts, USA., O'Brien FL; Alexion Pharmaceuticals, Inc., Boston, Massachusetts, USA., Mozaffar T; Department of Neurology, University of California, Irvine, California, USA.
Publikováno v:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Jul; Vol. 8 (7), pp. 1398-1407. Date of Electronic Publication: 2021 May 27.
Autor:
Mantegazza R; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Wolfe GI; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Muppidi S; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Wiendl H; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Fujita KP; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., O'Brien FL; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Booth HDE; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Howard JF Jr; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA. howardj@neurology.unc.edu.
Publikováno v:
Neurology [Neurology] 2021 Jan 26; Vol. 96 (4), pp. e610-e618. Date of Electronic Publication: 2020 Nov 23.
Autor:
Nowak RJ; Department of Neurology, Yale University School of Medicine, New Haven, CT, United States., Muppidi S; Department of Neurology and Neurosciences, Stanford University School of Medicine, Stanford, CA, United States., Beydoun SR; Department of Neurology, University of Southern California, Los Angeles, CA, United States., O'Brien FL; Alexion Pharmaceuticals, Boston, MA, United States., Yountz M; Alexion Pharmaceuticals, Boston, MA, United States., Howard JF Jr; Department of Neurology, University of North Carolina, Chapel Hill, NC, United States.
Publikováno v:
Frontiers in neurology [Front Neurol] 2020 Nov 24; Vol. 11, pp. 556104. Date of Electronic Publication: 2020 Nov 24 (Print Publication: 2020).
Autor:
Mantegazza R; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., O'Brien FL; Alexion Pharmaceuticals, Boston, MA., Yountz M; Alexion Pharmaceuticals, Boston, MA., Howard JF Jr; Department of Neurology, University of North Carolina, Chapel Hill, NC.
Publikováno v:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Aug; Vol. 7 (8), pp. 1327-1339. Date of Electronic Publication: 2020 Jul 22.
Autor:
Tokuyasu, Daiki1 (AUTHOR), Suzuki, Shigeaki1 (AUTHOR) sgsuzuki@keio.jp, Uzawa, Akiyuki2 (AUTHOR), Nagane, Yuriko3 (AUTHOR), Masuda, Masayuki4 (AUTHOR), Konno, Shingo5 (AUTHOR), Kubota, Tomoya6 (AUTHOR), Samukawa, Makoto7 (AUTHOR), Sugimoto, Takamichi8 (AUTHOR), Ishizuchi, Kei1 (AUTHOR), Oyama, Munenori1 (AUTHOR), Yasuda, Manato2 (AUTHOR), Akamine, Hiroyuki2 (AUTHOR), Onishi, Yosuke2 (AUTHOR), Suzuki, Yasushi9 (AUTHOR), Kawaguchi, Naoki10 (AUTHOR), Minami, Naoya11 (AUTHOR), Kimura, Takashi12 (AUTHOR), Takahashi, Masanori P.6 (AUTHOR), Murai, Hiroyuki13 (AUTHOR)
Publikováno v:
Annals of Clinical & Translational Neurology. May2024, Vol. 11 Issue 5, p1338-1346. 9p.